Cargando…
Inhibiting Metastatic Breast Cancer Cell Migration via the Synergy of Targeted, pH-triggered siRNA Delivery and Chemokine Axis Blockade
[Image: see text] Because breast cancer patient survival inversely correlates with metastasis, we engineered vehicles to inhibit both the C-X-C chemokine receptor type 4 (CXCR4) and lipocalin-2 (Lcn2) mediated migratory pathways. pH-responsive liposomes were designed to protect and trigger the relea...
Autores principales: | Guo, Peng, You, Jin-Oh, Yang, Jiang, Jia, Di, Moses, Marsha A., Auguste, Debra T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993942/ https://www.ncbi.nlm.nih.gov/pubmed/24467226 http://dx.doi.org/10.1021/mp4004699 |
Ejemplares similares
-
ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
por: Guo, Peng, et al.
Publicado: (2016) -
Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014) -
Evidence for chemokine synergy during neutrophil migration in ARDS
por: Williams, Andrew E, et al.
Publicado: (2017) -
The pH-Triggered Triblock Nanocarrier Enabled Highly Efficient siRNA Delivery for Cancer Therapy
por: Du, Lili, et al.
Publicado: (2017) -
Chemokine blockade
por: Wells, William A.
Publicado: (2007)